Cliff Asness's IBB Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 8,015 shares of iShares Biotechnology ETF (IBB) worth $1.35 M, representing 0.00% of the portfolio. First purchased in 2023-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Cliff Asness has maintained this position in IBB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 3,557 shares. Largest reduction occurred in Q3 2023, reducing 15,183 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2,853 | Add 55.27% | 8,015 | $168.78 |
| Q3 2025 | -201 | Reduce 3.75% | 5,162 | $144.37 |
| Q2 2025 | +1,806 | Add 50.77% | 5,363 | $126.51 |
| Q1 2025 | +3,557 | New Buy | 3,557 | $127.90 |
| Q3 2023 | -15,183 | Sold Out | 0 | $0.00 |
| Q2 2023 | +15,183 | New Buy | 15,183 | $126.96 |
Cliff Asness's iShares Biotechnology ETF Investment FAQs
Cliff Asness first purchased iShares Biotechnology ETF (IBB) in Q2 2023, acquiring 15,183 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held iShares Biotechnology ETF (IBB) for 6 quarters since Q2 2023.
Cliff Asness's largest addition to iShares Biotechnology ETF (IBB) was in Q2 2023, adding 15,183 shares worth $1.93 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 8,015 shares of iShares Biotechnology ETF (IBB), valued at approximately $1.35 M.
As of the Q4 2025 filing, iShares Biotechnology ETF (IBB) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in iShares Biotechnology ETF (IBB) was 15,183 shares, as reported at the end of Q2 2023.